Sandoz's Erelzi has become the first biosimilar of Amgen's Enbrel (etanercept) blockbuster inflammatory diseases drug to gain FDA approval. Erelzi (etanercept-szzs) has been approved in all uses ...

This photo shows signage outside the Amgen headquarters in Thousand Oaks, Calif on Nov. 9, 2014. (AP Photo/Mark J. Terrill, File) The pharmaceutical company Amgen has again sued Colorado over a state ...

In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has aggressively blocked competition for it. By Rebecca Robbins With a sticker price ...

The pharmacy of Denver Indian Health and Family Services is seen on April 13, 2023. (Olivia Sun, The Colorado Sun via Report for America) An obscure Colorado board took an unprecedented step last week ...

Doctors prescribe Enbrel for arthritis, psoriasis, and other conditions. The medication can cause side effects that are mild and some serious ones. Serious side effects of Enbrel include neurologic ...

Colorado’s prescription drug affordability board members indicated Friday they plan to use Medicare’s negotiated price for the autoimmune treatment Enbrel as a key benchmark for setting a limit on ...

Originally approved by the FDA in 1998, Amgen’s Enbrel is still sailing along without facing biosimilar competition in the United States. And unless a court rules otherwise, the Southern California ...

Sandoz and Amgen face off in a legal battle over market access for Enbrel biosimilars. Credit: Richard Drury via Getty Images. Sandoz has filed an antitrust lawsuit in the US against Amgen, ...

People with rheumatoid arthritis often take medicines to help manage their condition and improve their symptoms. Some of these medicines work directly on the body’s immune system and help to limit the ...

Getting your Trinity Audio player ready... A drugmaker whose product could be the first subjected to a price cap in Colorado is suing to throw out the state board that deemed its medication ...